The startup behind chatbot sensation ChatGPT announced the release of a long-awaited update of its artificial intelligence (AI) model. OpenAI said in a blog post that its latest AI technology, GPT-4, is a large "multimodal model" that “exhibits human-level performance on various professional and academic benchmarks.”
Highlighting the strength of the powerful AI, the company said the score of its previous AI model, GPT-3.5, in a simulated bar exam was around the bottom 10% of test takers while GPT-4 passed it with a score around the top 10%.
The distinction between GPT-3.5 and GPT-4 are more pronounced when the complexity of the task reaches a sufficient threshold where the latter is more reliable, creative, and able to handle much more nuanced instructions than GPT-3.5, according to the OpenAI.
"We’ve spent 6 months iteratively aligning GPT-4 using lessons from our adversarial testing program as well as ChatGPT, resulting in our best-ever results (though far from perfect) on factuality, steerability, and refusing to go outside of guardrails."
Billionaire investor Elon Musk, who has also co-founded a brain-chip company Neuralink that develops implantable brain–computer interfaces, responded to a tweet about ChatGPT-4 acing exams, wondering what would be left for humans to do.
“We better get a move on with Neuralink!” he added.
{{/usCountry}}“We better get a move on with Neuralink!” he added.
{{/usCountry}}Neuralink, founded in 2016, is yet to receive approval from US Food and Drug Administration to test its brain chip in humans.
Musk has predicted several times that his brain-chip company, Neuralink, would soon secure FDA approval for human trials but the company's application was rejected in early 2022, reported Reuters citing company staffers.
In November 2022, Musk tweeted: “We are now confident that the Neuralink device is ready for humans, so timing is a function of working through the FDA approval process.” At Neuralink’s livestreamed “show-and-tell” presentation, Musk said that he expects the device to be in humans in six months, and that he considers it safe enough for his own children.